Argus downgraded Hologic (HOLX) to Hold from Buy as the company had agreed in October to be acquired by funds managed by Blackstone (BX) and TPG (TPG) in a transaction valued at up to $79 per share, representing an enterprise value of up to $18.3B. The transaction is expected to close in early February, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HOLX:
- Hologic downgraded to Hold from Buy at Argus
- Evercore ISI upgrades four, downgrades six in MedTech and Tools
- Hologic downgraded to In Line from Outperform at Evercore ISI
- Hologic downgraded to Neutral from Outperform at BNP Paribas Exane
- Hologic’s Financial Health at Risk: Navigating Reimbursement and Guideline Challenges